Improving antibiotic treatment of bacterial biofilm by hyperbaric oxygen therapy: Not just hot air
- PMID: 33447795
- PMCID: PMC7798444
- DOI: 10.1016/j.bioflm.2019.100008
Improving antibiotic treatment of bacterial biofilm by hyperbaric oxygen therapy: Not just hot air
Abstract
Bacteria and fungi show substantial increased recalcitrance when growing as infectious biofilms. Chronic infections caused by biofilm growing microorganisms is considered a major problem of modern medicine. New strategies are needed to improve antibiotic treatment of biofilms. We have improved antibiotic treatment of bacterial biofilms by reviving the dormant bacteria and thereby make them susceptible to antibiotics by means of reoxygenation. Here we review the rationale for associating lack of oxygen with low susceptibility in infectious biofilm, and how hyperbaric oxygen therapy may result in reoxygenation leading to enhanced bactericidal activity of antibiotics. We address issues of feasibility and potential adverse effects regarding patient safety and development of resistance. Finally, we propose means for supplying reoxygenation to antibiotic treatment of infectious biofilm with the potential to benefit large groups of patients.
Keywords: Antibiotics; Biofilm; Hyperbaric oxygen; Susceptibility.
© 2019 The Author(s).
Conflict of interest statement
No conflicts of interest.
Figures
Similar articles
-
Reinforcement of the bactericidal effect of ciprofloxacin on Pseudomonas aeruginosa biofilm by hyperbaric oxygen treatment.Int J Antimicrob Agents. 2016 Feb;47(2):163-7. doi: 10.1016/j.ijantimicag.2015.12.005. Epub 2015 Dec 29. Int J Antimicrob Agents. 2016. PMID: 26774522
-
Hyperbaric Oxygen Sensitizes Anoxic Pseudomonas aeruginosa Biofilm to Ciprofloxacin.Antimicrob Agents Chemother. 2017 Oct 24;61(11):e01024-17. doi: 10.1128/AAC.01024-17. Print 2017 Nov. Antimicrob Agents Chemother. 2017. PMID: 28874373 Free PMC article.
-
Biofilms as Promoters of Bacterial Antibiotic Resistance and Tolerance.Antibiotics (Basel). 2020 Dec 23;10(1):3. doi: 10.3390/antibiotics10010003. Antibiotics (Basel). 2020. PMID: 33374551 Free PMC article. Review.
-
The clinical impact of bacterial biofilms.Int J Oral Sci. 2011 Apr;3(2):55-65. doi: 10.4248/IJOS11026. Int J Oral Sci. 2011. PMID: 21485309 Free PMC article. Review.
-
Combination drug strategies for biofilm eradication using synthetic and natural agents in KAPE pathogens.Front Cell Infect Microbiol. 2023 Apr 17;13:1155699. doi: 10.3389/fcimb.2023.1155699. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37139491 Free PMC article. Review.
Cited by
-
Use of Hyperbaric Oxygen in Patients with Necrotizing Soft Tissue Infections: A Scandinavian Multicenter, Prospective, Observational Cohort.Infect Dis Ther. 2025 Aug;14(8):1715-1738. doi: 10.1007/s40121-025-01184-5. Epub 2025 Jul 4. Infect Dis Ther. 2025. PMID: 40613866 Free PMC article.
-
Hyperbaric Oxygen Therapy as a Renewed Hope for Ischemic Craniomaxillofacial Diseases.Healthcare (Basel). 2025 Jan 13;13(2):137. doi: 10.3390/healthcare13020137. Healthcare (Basel). 2025. PMID: 39857164 Free PMC article. Review.
-
Oxygen and Metabolism: Digesting Determinants of Antibiotic Susceptibility in the Gut.iScience. 2020 Nov 30;23(12):101875. doi: 10.1016/j.isci.2020.101875. eCollection 2020 Dec 18. iScience. 2020. PMID: 33354661 Free PMC article. Review.
-
Photodynamic disinfection and its role in controlling infectious diseases.Photochem Photobiol Sci. 2021 Nov;20(11):1497-1545. doi: 10.1007/s43630-021-00102-1. Epub 2021 Oct 27. Photochem Photobiol Sci. 2021. PMID: 34705261 Free PMC article. Review.
-
pH variation in medical implant biofilms: Causes, measurements, and its implications for antibiotic resistance.Front Microbiol. 2022 Oct 31;13:1028560. doi: 10.3389/fmicb.2022.1028560. eCollection 2022. Front Microbiol. 2022. PMID: 36386694 Free PMC article. Review.
References
-
- Jensen P.Ø., Kolpen M., Kragh K.N., Kühl M. Micro-environmental characteristics and physiology of biofilms in chronic infections of CF patients are strongly affected by the host immune response. APMIS. 2017;125:276–288. - PubMed
-
- Høiby N., Bjarnsholt T., Moser C., Jensen P.Ø., Kolpen M., Qvist T., Aanaes K., Pressler T., Skov M., Ciofu O. Diagnosis of biofilm infections in cystic fibrosis patients. APMIS. 2017;125:339–343. - PubMed
-
- Kidd T.J., Canton R., Ekkelenkamp M., Johansen H.K., Gilligan P., LiPuma J.J., Bell S.C., Elborn J.S., Flume P.A., VanDevanter D.R., Waters V.J. Antimicrobial resistance in cystic fibrosis international working G. Defining antimicrobial resistance in cystic fibrosis. J Cyst Fibros Off J Eur Cyst Fibros Soc. 2018;17:696–704. - PubMed
-
- Flume P.A., Waters V.J., Bell S.C., Van Devanter D.R., Stuart Elborn J. Antimicrobial resistance in cystic fibrosis international working G. Antimicrobial resistance in cystic fibrosis: does it matter? J Cyst Fibros Off J Eur Cyst Fibros Soc. 2018;17:687–689. - PubMed
Publication types
LinkOut - more resources
Full Text Sources